Hepion Pharmaceuticals, Inc.
New Filing
CIK: 0001583771·Pharmaceuticals·DELAWARE·Filed: Oct 3, 2023
Total Offering
$5,000,004
Amount Sold
$5,000,004
Investors
1
First Sale
Sep 28, 2023
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Robert Foster | Related Person |
| John Cavan | Related Person |
| Anand Reddi | Related Person |
| Gary S. Jacob | Related Person |
| John P. Brancaccio | Related Person |
| Timothy Block | Related Person |
| Kaouthar Lbiati | Related Person |
| Petrus Wijngaard | Related Person |
Company
SEC Filing
0001104659-23-106467
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free